EFPIA: pharmaceutical industry must play a key role in medical reform

Source: Ding Xiangyuan 2014-06-16 due to the conflict between austerity measures and increased demand for medical services, European health care is still under extreme pressure, but according to the information provided by the European Federation of pharmaceutical industry associations (EFPIA), with the stability of the economy, it is now the time to reform the medical system EFPIA went even further in the declaration just released The association suggested that the pharmaceutical industry should be positioned as "the core of European economic reform and development" Sanofi Chris Viehbacher, EFPIA's chairman and chief executive officer, said: "medical spending can only be controlled if there is a significant improvement in health and increased support for innovation." EFPIA wants the medical and life sciences sector to be seen not only as healthcare, but also as a pillar of the EU's economic prosperity Europe still accounts for about one-third of global drug R & D expenditure, which is still relatively stable Europe cannot take for granted the competitiveness of its pharmaceutical industry in the future, because its share of global R & D investment and the proportion of new drugs on the market are at the lowest level ever " Source address: http://www.pmlive.com/pharma'news/effia'pharma'must'play'key'role'in'healthcare'reform'576760